@_danmeyer

CEO @cellchorus (dynamic single-cell functional analysis)

 San Mateo, CA
cellchorus.com
Joined February 2010
  • Tweets1.1K
  • Following17
  • Followers306
61Media
Congrats to @sunilacharya13, @lab_rezvani & collaborators for publishing in Cancer Discovery how CD28 costimulation enhances CAR-NK cell function! CAR27 NK cells with CD28-based costimulation were ~3x more likely to exhibit serial killing. Learn more: cellchorus.com/news/cancer-d…
2
1
15
1,400
104 Nobel Prizes have been won by NIH researchers But yeah shut it down
174
1,424
36
5,394
109,964
Dan Meyer retweeted
GenomeWeb@GenomeWeb11 Oct 2024
In Brief This Week: Bruker, Qiagen, Prenetics, CellChorus, T2 Biosystems, More genomeweb.com/business-news/…

In Brief This Week: Bruker, Qiagen, Prenetics, CellChorus, T2 Biosystems, More

News items for the week of Oct. 7, 2024.

genomeweb.com
2
3
409
Attending #SITC24 this week?Be sure to check out the 𝒇𝒐𝒖𝒓 presentations featuring data from @CellChorus' single-cell analysis technology! cellchorus.com/news/four-abs…

Four abstracts at SITC 2024 to feature TIMING data — CellChorus

Four abstracts at SITC 2024 to feature TIMING data. Applications of TIMING data include screening donors, enhancing ADCC, quantifying potency/viability, and more.

cellchorus.com
1
2
2
245
Attending SITC 2024? Four abstracts from CellChorus and collaborators feature TIMING data! Join us to learn how dynamic single-cell analysis improves screening donors, enhancing ADCC, quantifying potency/viability, and more. cellchorus.com/news/four-abs… @sitcancer

Four abstracts at SITC 2024 to feature TIMING data — CellChorus

Four abstracts at SITC 2024 to feature TIMING data. Applications of TIMING data include screening donors, enhancing ADCC, quantifying potency/viability, and more.

cellchorus.com
2
2
3
542
Want to learn how to apply TIMING™ for potency and viability analysis in process development? Meet with us at BioProcess International in Boston Sept 25th + 26th. Already registered? Book a meeting in the conference app: lnkd.in/g3nu5HHS @BioProcessIntl @InformaConnect
1
1
66
🚨 @IndeeLabs posted a manuscript that applies TIMING™ data from @CellChorus to show that CAR-T cells manufactured with the Indee platform have superior motility and resistance to activation-induced cell death (AICD). biorxiv.org/content/10.1101/… @RBerdeaux @MohsenFathi1993
1
7
9
11,185
💥Publication alert: CAR T cells from individuals with complete response were enriched for migration and serial killing. Learn more about the TIMING™ data: cellchorus.com/news/nature-c… @NatureCancer @UH_NVLab @MohsenFathi1993 #singleCellAnalysis #CART #cellTherapy

Nature Cancer publication identifies a clinically effective subset of CAR T cells — CellChorus

Scientists from a comprehensive cancer center and one of the only companies with an approved CAR T cell therapy demonstrate the potential for applying TIMING to identify patients that are likely to...

cellchorus.com
Nature Cancer@NatureCancer17 May 2024
Check out the latest articles @NatureCancer "Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling" doi.org/10.1038/s43018-024-0…
1
3
137
YC S21's @CellChorus has received $2.5 million in support from @ncats_nih_gov @NIH to extend its TIMING™ single-cell analysis platform that quantifies which immune cells perform best and why. genomeweb.com/business-news/…
2
20
13,650
Researchers from the @UH_NVLab at @UHouston have applied TIMING™ data to study redundancies in cytotoxic mechanisms employed by CAR T cells. See an example nanowell video below and the paper in Cell Death & Disease: nature.com/articles/s41419-0… #singleCell #leukemia #immunooncology
1
4
128
Join @CellChorus at #SLAS2024 in Boston! @RBerdeaux will present on Monday Feb 5 at 10:30 in the Precision Medicine in Immunotherapy session. @SLAS_Org #singleCell #immunotherapy #ImmunoOncology #CarT #CarNK #antibodies
2
3
101
Andrew J. Last, PhD, (ECP & COO of @BioRad) has joined the CellChorus board of directors! Learn more: cellchorus.com/news/cellchor…
2
3
182
.@CellChorus is a perfect example of how #tech giants are embracing the marriage between #computation and #biology. It's exciting to see! Congrats, team, on getting into the program!
CellChorus@CellChorus25 Jul 2023
Thank you to the @NVIDIA Inception team for their support! @CellChorus applies AI to evaluate how immune cells move, interact and perform over time cellchorus.com/news/cellchor… #ai #artificialIntelligence #ml #machineLearning #cellTherapy #immunotherapy #immunooncology #singleCell

CellChorus joins NVIDIA Inception — CellChorus

CellChorus has joined NVIDIA Inception, a program designed to nurture startups revolutionizing industries with advancements in artificial intelligence (AI) and data sciences.

cellchorus.com
2
3
376
Thank you to the @NVIDIA Inception team for their support! @CellChorus applies AI to evaluate how immune cells move, interact and perform over time cellchorus.com/news/cellchor… #ai #artificialIntelligence #ml #machineLearning #cellTherapy #immunotherapy #immunooncology #singleCell

CellChorus joins NVIDIA Inception — CellChorus

CellChorus has joined NVIDIA Inception, a program designed to nurture startups revolutionizing industries with advancements in artificial intelligence (AI) and data sciences.

cellchorus.com
1
1
3
483
Dan Meyer retweeted
GenomeWeb@GenomeWeb28 Jun 2023
CellChorus Wins Phase I National Science Foundation SBIR Grant. The award will support development of microscale arrays for single-cell analysis in the life sciences industry. ow.ly/mzc6104Mih9

CellChorus Wins Phase I National Science Foundation SBIR Grant

The award will support development of microscale arrays for single-cell analysis in the life sciences industry.

genomeweb.com
2
2
402
"Amid international VC decline, here's what Houston startups received investment, grant funding last quarter" @nataliejharms and @AliceEats via @InnoMapHou houston.innovationmap.com/q2… #singleCell #ai #ml #immunotherapy #cellTherapy #immunoOncology

Amid international VC decline, here's what Houston startups received investment, grant funding last...

The second quarter of 2023 looked a lot like the first when it came to venture capital funding for Houston companies. The whole country — affected by inflation, geopolitical instability, and other...

houston.innovationmap.com
1
2
85
The @NIH has awarded @CellChorus (YC S21) $2.3M to scale its visual AI technology that predicts cell response to life-saving immunotherapies, enabling scientists to create new medications faster, at lower cost, and with a higher success rate. houston.innovationmap.com/ce…

Houston biotech startup secures $2.3M grant

They say it’s all in the timing. For CellChorus, it’s all in the TIMING. That’s Time-lapse Imaging Microscopy In Nanowell Grids. TIMING is a visual AI program that evaluates cell activation, killing...

houston.innovationmap.com
1
4
23
12,293
The city limits of Houston have complex topology. The city is not simply simply connected, not in the technical sense of the term nor in the colloquial sense.
1
18
2
83
12,725
Dynamic single-cell analysis is a powerful approach for directly evaluating cytotoxicity and exhaustion of individual cells, especially when the field lacks clear phenotypic markers of NK cell exhaustion. #singleCell #CARNK #cellTherapy #immunotherapy #immunoOncology #TIMING
Nature Medicine
@NatureMedicine29 Sep 2022
A new dual-chimeric antigen receptor (CAR) system enhances the antitumor activity of CAR natural killer cells and makes them less susceptible to therapeutic #resistance in preclinical models. @lab_rezvani #CARNK #therapyresistance nature.com/articles/s41591-0…
4
7
A new dual-chimeric antigen receptor (CAR) system enhances the antitumor activity of CAR natural killer cells and makes them less susceptible to therapeutic #resistance in preclinical models. @lab_rezvani #CARNK #therapyresistance nature.com/articles/s41591-0…
18
36
Load more